BLCO Bausch + Lomb Corporation Net earnings per share (EPS TTM)

Public company logo of Bausch + Lomb (BLCO)

Bausch + Lomb Corporation (BLCO) relies on resilient demand in ophthalmology, which guarantees stable margins. However, high debt and market pressure limit capital inflows. The 12-month earnings per share history clearly demonstrates yield dynamics, where the -0.31 level serves as a critical mark. Regular cash flow from global sales fully covers investments in new developments.

BLCO Bausch Health Net earnings per share for the last four quarters (04/28/2023 - 11/18/2026)

Summary analytical data breakdowns for Bausch + Lomb Corporation (BLCO)

- share price and expert price forecast:
Analysis of all company metrics:BLCO - Bausch & Lomb
Manufactured products of Bausch Health

By scaling the expansion of innovative lenses and surgical equipment, Bausch + Lomb Corporation (BLCO) is transforming operating revenue into real shareholder returns. An analysis of earnings per share over the last four quarters allows for an assessment of this strategy's effectiveness, as the metric normalizes the bottom line relative to the total number of outstanding securities, determining the business's fundamental stability and the objectivity of its market value.

Competitors of Bausch + Lomb Corporation

Alcon Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Glaukos|APLS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months belitebio.com (BLTE)|Earnings per share for the last twelve months ocutx.com|Harrow, Inc. (HROW) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months VRDN (Viridian Therapeutics, Inc.)|Earnings per share for the last twelve months LENZ (LENZ Therapeutics)|Earnings per share for the last twelve months Oculis AG OCS|EyePoint Pharma (EYPT) - Net earnings per one share for the last twelve months|kodiak.com - Net earnings per share (EPS TTM)|ALDX (aldeyra.com) - Earnings per share for the last 12 months|KALA: Net earnings per share (EPS TTM)|Opus Genetics, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months OKYO|ADVM: Earnings per share for the trailing year|Earnings per share for the last twelve months Outlook Therapeutics Inc (OTLK)|Net earnings per share for the last four quarters Clearside Biomedical|NovaBay Pharmaceuticals - Net earnings per share for the last 12 months|KPRX (Kiora Pharma) - Earnings per one share for the last 12 months|ALIM: Net earnings per share for the last 12 months|EYEN - Net earnings per share (EPS TTM)|GHSI (Guardion Health Science) - Net earnings per share for the last 12 months|ocuphire.com - Earnings per share for the trailing year|OPT (Opthea Ltd) - Net earnings per share (EPS TTM)